Literature DB >> 6779623

Comparison of minimum inhibitory concentration values determined by three antimicrobic dilution methods for Pseudomonas aeruginosa.

B F Woolfrey, J M Fox, C O Quall.   

Abstract

This investigation compares minimum inhibitory concentration measurements by three antimicrobic dilution methods for Pseudomonas aeruginosa versus seven antimicrobics. Minimum inhibitory concentrations were measured for 650 P. aeruginosa clinical isolates and for repeated tests with P. aeruginosa ATCC 27853 versus gentamicin, tobramycin, amikacin, netilmicin, sisomicin, carbenicillin, and ticarcillin, using the macro-broth, micro-broth, and agar dilution methods. For all antimicrobics, it was found that the micro-broth and agar dilution methods produced comparable minimum inhibitory concentration measurements, which were found to lie 1 to 2 double dilution steps below those determined by the macro-broth method. Acceptably replicability was found for both the macro-broth and the agar dilution methods. The micro-broth method showed less replicability, with 4.7% of minimum inhibitory concentration values lying +/- 2 or more double dilution steps from the modal value. It is important to recognize such differences if micro-broth or agar dilution methods are substituted for the macro-broth method.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6779623     DOI: 10.1093/ajcp/75.1.39

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  11 in total

1.  Evaluation of Alamar colorimetric MIC method for antimicrobial susceptibility testing of gram-negative bacteria.

Authors:  C N Baker; S N Banerjee; F C Tenover
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

2.  Comparative evaluation of the micro-media system, sceptor, and MIC-2000 microdilution methods for testing Pseudomonas aeruginosa against gentamicin, tobramycin, and amikacin.

Authors:  B F Woolfrey; R T Lally; C O Quall
Journal:  J Clin Microbiol       Date:  1983-02       Impact factor: 5.948

3.  Pseudomonas aeruginosa ATCC 49189, a new quality control strain for testing P. aeruginosa susceptibility to the aminoglycosides.

Authors:  R T Lally; B F Woolfrey; M A Enright
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

4.  Evaluation of the automicrobic system for susceptibility testing of Pseudomonas aeruginosa to gentamicin, tobramycin, and amikacin.

Authors:  B F Woolfrey; R T Lally; M N Ederer; C O Quall
Journal:  J Clin Microbiol       Date:  1984-04       Impact factor: 5.948

5.  Wide variability in Pseudomonas aeruginosa aminoglycoside results among seven susceptibility testing procedures.

Authors:  J L Staneck; S Glenn; J R DiPersio; P A Leist
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

6.  Error rates associated with the use of recently proposed breakpoints for testing Pseudomonas aeruginosa versus gentamicin, tobramycin, and amikacin by the standardized disk agar diffusion test.

Authors:  B F Woolfrey; J M Fox; C O Quall; R T Lally
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

7.  Comparison of the Sceptor Pseudomonas Plus MIC Panel with agar dilution for susceptibility testing of Pseudomonas aeruginosa.

Authors:  L F Joyce; K Stockman; J Downes; J H Andrew
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

8.  Comparison of five methods, including the PDM Epsilometer test (E test), for antimicrobial susceptibility testing of Pseudomonas aeruginosa.

Authors:  L F Joyce; J Downes; K Stockman; J H Andrew
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

9.  Broth microdilution testing of Pseudomonas aeruginosa and aminoglycosides: need for employing dilutions differing by small arithmetic increments.

Authors:  B F Woolfrey; J M Fox; R T Lally; C O Quall
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948

10.  Efficacy of intermittent versus continuous administration of netilmicin in a two-compartment in vitro model.

Authors:  J Blaser; B B Stone; S H Zinner
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.